liposomal glutathione oral bioavailability randomized trial evidence outperforms plain glutathione in uptake, cell regeneration and systemic availability: from cellular and human models A Targeted Metabolomic Assessment of – liposomal glutathione oral bioavailability study

Please contact us for your free consultation

Utilizing AIM2 / mice in a diethylnitrosamine-induced hepatocellular carcinoma model, research has demonstrated that AIM2 inflammasome activation in Kupffer cells promotes inflammation-associated tumor initiation in the liver

Each batch undergoes particle-size verification (100-300nm), encapsulation integrity testing, and stability assessment before release, ensuring consistent potency

Experimental design After 20 days of growth, tissue culture plantlets were divided into five groups for experimental treatment: (1) T0 (untreated), (2) Cd48 (48 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), (3) GSH48 (48 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution), (4) Cd96 (96 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), and (5) GSH96 (96 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution)